Efficacy of the 1-year (13-cycle) segesterone acetate and ethinylestradiol contraceptive vaginal system: results of two multicentre, open-label, single-arm, phase 3 trials

BACKGROUND: A ring-shaped, contraceptive vaginal system designed to last 1 year (13 cycles) delivers an average of 0·15 mg segesterone acetate and 0·013 mg ethinylestradiol per day. We evaluated the efficacy of this contraceptive vaginal system and return to menses or pregnancy after use. METHODS: I...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Lancet Glob Health
Main Authors: Archer, David F, Merkatz, Ruth B, Bahamondes, Luis, Westhoff, Carolyn L, Darney, Philip, Apter, Dan, Jensen, Jeffrey T, Brache, Vivian, Nelson, Anita L, Banks, Erika, Bártfai, György, Portman, David J, Plagianos, Marlena, Dart, Clint, Kumar, Narender, Creasy, George W, Sitruk-Ware, Regine, Blithe, Diana L
Formato: Artigo
Idioma:Inglês
Publicado em: Elsevier Ltd 2019
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6624423/
https://ncbi.nlm.nih.gov/pubmed/31231065
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/S2214-109X(19)30265-7
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados